Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Style
News
Style
News
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
About – Contact
Institutional Investors
Analysts
Side Stories
Disclaimer
Search
Search
Login
HOME
Universe A-Z
PSYCH STOCK NEWS
PSYCH NEWS
RESEARCH
TESTIMONIALS
CLINICAL TRIALS
CONFERENCES
2024 PSYCHEDELIC INVESTOR CONFERENCE
SEARCH BY SYMBOL
Home
Search
Search
2024 WATCH LIST
Interview: MAPS Founder Rick Doblin and Clearmind Medicine (CMND) CEO, Adi Zuloff-Shani.
Editor | Curator
-
April 3, 2024
ALCOHOL
1000 Days Without Alcohol: Here’s What Happened
Editor | Curator
-
February 7, 2024
CLINICS
Startup Ketamine Clinic ‘Being Health’ Raises $5.4 Million
Editor | Curator
-
January 30, 2024
CLINICS
Journey Medical’s Growing Army of 1,000 Ketamine Therapists, are Available 24-7. Pure Genius. Interview With Jonathan Sabbagh, CEO
Editor | Curator
-
January 30, 2024
CONFERENCES
Guide to Miami Hedge Fund Week 2024
Editor | Curator
-
January 30, 2024
CLINICS
Helping Ketamine Clinics Succeed. Beyond Marketing.
Editor | Curator
-
January 27, 2024
PSYCH NEWS
Lykos Therapeutics (formerly MAPS) Raises $100 Million. Cha-Ching.
Editor | Curator
-
January 23, 2024
2024 Psychedelic Investor Conference
Editor | Curator
-
October 30, 2023
Subscribe for Free!
Editor | Curator
-
August 9, 2021
2021 Psychedelic Investor Guide.
Editor | Curator
-
August 8, 2021
ALL PSYCHEDELIC AND PSYCHEDELIC STOCK NEWS
Psychedelic Therapeutics Sector Outlook Released (Valhalla Ventures)
RESEARCH
Editor | Curator
-
October 18, 2021
Valhalla Ventures backs visionary founders at the forefront of social and technological movements that younger generations care about most.
View Post
2021 Psychedelic Investor Guide Released.
Psychedelic Investor Guide
Editor | Curator
-
October 18, 2021
Institutional Analyst Inc. announced the release of the 2021 Psychedelic Investor Guide on Monday, October 18th. The Psychedelic Investor Guide is the...
View Post
Psychedelic Investor TV
INTERVIEW
Editor | Curator
-
October 18, 2021
To appear on an upcoming episode on Psychedelic Investor TV in conjunction with New to the Street TV airing on News Max,...
View Post
2021 Psychedelic Investor Guide – October
Psychedelic Investor Guide
Editor | Curator
-
October 17, 2021
OPEN GUIDE Updated Monthly.. Did we miss your publicly traded company?...
View Post
Ketamine Testimonials On Local Nashville and Miami News. Lamar Odom on Good Morning America.
TESTIMONIALS
Editor | Curator
-
October 16, 2021
News Channel 5 Nashville. Ketamine infusions are being used to treat patients with severe depression. The medicine is also a treatment...
View Post
Pasithea Therapeutics (KTTA) Opens its First Ketamine Therapy Clinic in the United Kingdom
CLINICS
Editor | Curator
-
October 15, 2021
Pasithea Therapeutics recently raised $24 million at its initial public offering (“IPO”). The Company’s Common Stock began trading on The Nasdaq...
View Post
Ehave (EHVVF) To Conduct Ketamine Clinical Trial In Miami, Florida
Featured
Editor | Curator
-
October 13, 2021
"I believe that we are on the verge of curing, as opposed to simply treating, certain psychiatric maladies." Dr. Jeffrey Kamlet,...
View Post
18 Psychedelic Experts Presenting (Bios).
CONFERENCES
Editor | Curator
-
October 12, 2021
KCSA PSYCHEDELIC INVESTOR CONFERENCE PRESENTERS Awaken (AWKN) CEO Anthony Tennyson
View Post
KCSA Psychedelics Conference. Wednesday, October 13th.
CONFERENCES
Editor | Curator
-
October 11, 2021
The KCSA Psychedelics Conference features live presentations and speakers who will address the various investment opportunities in...
View Post
Psychedelic Stock Review Initiates Coverage on Ehave Inc.
PSYCH STOCK NEWS
Editor | Curator
-
October 2, 2021
Psychedelic Stock Review Initiates Coverage on Ehave Inc. MIAMI, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink:...
View Post
Interview: Great Interview With Cybin (CYBN) CEO Doug Drysdale.
INTERVIEW
Editor | Curator
-
September 29, 2021
https://youtu.be/JXNEmACes2U?t=605 Interview start at 10:00 mark. LIVE QUOTE It...
View Post
Conference: Replay of Advances in Mental Health. M-Vest & Maxim Group LLC.
CONFERENCES
Editor | Curator
-
September 28, 2021
One of the best Conferences we have viewed to date, and being on replay it can be viewed at your leisure and/or...
View Post
Ehave (EHVVF) Announces Inclusion in the 2021 Psychedelic Investor Guide
PSYCH STOCK NEWS
Editor | Curator
-
September 27, 2021
MIAMI, Sept. 27, 2021 (GLOBE NEWSWIRE) — Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic...
View Post
1
...
4
5
6
...
11
Page 5 of 11
KetaDash
Ketamine at Home Treatments
RESEARCH
Most Popular
Interview: MAPS Founder Rick Doblin and Clearmind Medicine (CMND) CEO, Adi Zuloff-Shani.
2024 WATCH LIST
Editor | Curator
-
April 3, 2024
INTRO VIDEO https://youtu.be/-RQikn6O3qw?si=o_IBy9yTlmfNNvky Join Clearmind Medicine CEO, Adi Zuloff-Shani,...
1000 Days Without Alcohol: Here’s What Happened
ALCOHOL
Editor | Curator
-
February 7, 2024
No..we didn't give up drinking - at least not yet. But we RUMinate about it from time to time. At a dinner...
Startup Ketamine Clinic ‘Being Health’ Raises $5.4 Million
CLINICS
Editor | Curator
-
January 30, 2024
This startup is opening a mental health clinic that offers ketamine therapy. BusinessInsider got an exclusive look at the pitch deck it...
Trending Now
Interview: MAPS Founder Rick Doblin and Clearmind Medicine (CMND) CEO, Adi Zuloff-Shani.
1000 Days Without Alcohol: Here’s What Happened
Startup Ketamine Clinic ‘Being Health’ Raises $5.4 Million
Non-Hallucinogenic Psychedelics or Short Term vs Long Term Acting Psychedelics, Which are Best.
Journey Medical’s Growing Army of 1,000 Ketamine Therapists, are Available 24-7. Pure Genius. Interview With Jonathan Sabbagh, CEO
LARGE CAP PSYCHEDELIC STOCKS
ATAI to Invest $50 Million in Beckley Psytech
Editor | Curator
-
January 21, 2024
Is ATAI Live Sciences (ATAI) $2.00, Finally Turning?
Editor | Curator
-
April 24, 2023
Australian Icannex (IHL:ASX) Headed to NASDAQ?
Editor | Curator
-
February 10, 2022
PSYCHEDELIC FUNDS AND ETFS
AdvisorShares Psychedelics ETF (PSIL)
Editor | Curator
-
September 21, 2021
Novamind (NVMDF) Announces Inclusion in NYSE Listed AdvisorShares Psychedelics ETF (PSIL)
Editor | Curator
-
September 20, 2021
Horizons Psychedelic Index ETF.
Editor | Curator
-
September 17, 2021